Precision Biosciences (DTIL) Cash from Operations (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) Cash from Operations (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.11% |
| Dec 31, 2025 | 26.33% |
| Sep 30, 2025 | 24.67% |
| Jun 30, 2025 | -6.40% |
| Mar 31, 2025 | -1.98% |
| Dec 31, 2024 | -216.02% |
| Sep 30, 2024 | 60.24% |
| Jun 30, 2024 | 21.66% |
| Mar 31, 2024 | -125.35% |
| Dec 31, 2023 | 63.53% |
| Sep 30, 2023 | -9.27% |
| Jun 30, 2023 | 32.83% |
| Mar 31, 2023 | -44.05% |
| Dec 31, 2022 | -174.84% |
| Sep 30, 2022 | 220.48% |
| Jun 30, 2022 | 16.10% |
| Mar 31, 2022 | -21.92% |
| Dec 31, 2021 | 0.94% |
| Sep 30, 2021 | 23.72% |
| Jun 30, 2021 | -146.04% |